Barclays PLC Reaffirms a oeEqual weighta Rating for GlaxoSmithKline plc

Barclays PLC Reaffirms a oeEqual weighta Rating for GlaxoSmithKline plc


Complete the form below to receive the latest headlines and analysts' recommendationsfor GlaxoSmithKline plc with our free daily email newsletter: 's stock had its "equal weight" rating restated by equities research analysts at Barclays PLC in a research report issued on Tuesday, May 2nd. They presently have a GBX 1,550 target price on the stock.



from Biotech News